Cite Filings / ACRV / 0000950170-23-061553
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Acrivon Therapeutics, Inc. · Filed 2023-11-09 · Acc 0000950170-23-061553

Documents 1

  • 10-Q Quarterly Report , acrv-20230930.htm

Around this filing

  • 2024-05-14 10-Q Quarterly Report
  • 2023-11-16 4 Chief Financial Officer gave up 1,470 shares (to pay taxes)
  • 2023-11-16 4 Chief Operating Officer gave up 2,450 shares (to pay taxes)
  • 2023-11-16 4 President and CEO gave up 239,023 shares (to pay taxes)
  • 2023-11-09 8-K Results of operations · Regulation FD disclosure
  • 2023-11-09 10-Q Quarterly Report
  • 2023-08-11 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading acrv-20230930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…